Dear Reader,
As we reach the final issue of the American Journal of Cardiovascular Drugs for 2019, we wish to reflect on another successful year’s achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content.
2019 was a successful year for the American Journal of Cardiovascular Drugs. Over 50 articles have been published; the most popular of these, in terms of downloads from SpringerLink, have been:
Sugawara M, Goto Y, Yamazaki T, Teramoto T, Oikawa S, Shimada K, Uchiyama S, Ando K, Ishizuka N, Murata M, Yokoyama K, Uemura Y, Ikeda Y; Japanese Primary Prevention Project (JPPP) Study Group. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70). Am J Cardiovasc Drugs. 2019 Jun;19(3):299–311. https://doi.org/10.1007/s40256-018-0313-0.
Han SN, Yang WH, Yin JJ, Tao HL, Zhang LR. Drug Treatment of Hyperlipidemia in Chinese Patients: Focus on the Use of Simvastatin and Ezetimibe Alone and in Combination. Am J Cardiovasc Drugs. 2019 Jun;19(3):237–247. https://doi.org/10.1007/s40256-018-00317-1.
Goyal N, Skrdla P, Schroyer R, Kumar S, Fernando D, Oughton A, Norton N, Sprecher DL, Cheriyan J. Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects. Am J Cardiovasc Drugs. 2019 Jun;19(3):335–342. https://doi.org/10.1007/s40256-018-00320-6.
Deedwania P, Acharya T. Cardiovascular Protection with Anti-hyperglycemic Agents. Am J Cardiovasc Drugs. 2019 Jun;19(3):249–257. https://doi.org/10.1007/s40256-019-00325-9.
Garonzik S, Byon W, Myers E, Li X, Marchisin D, Murthy B. The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study. Am J Cardiovasc Drugs. 2019; 19(6):1–7. https://doi.org/10.1007/s40256-019-00348-2.
Nicholls SJ, Nelson AJ. Rivaroxaban With or Without Aspirin for the Secondary Prevention of Cardiovascular Disease: Clinical Implications of the COMPASS Trial. Am J Cardiovasc Drugs. 2019 Aug;19(4):343–348. https://doi.org/10.1007/s40256-018-00322-4.
Feng Y, Huang R, Kavanagh J, Li L, Zeng X, Li Y, Fu P. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis. Am J Cardiovasc Drugs. 2019 Jun;19(3):259–286. https://doi.org/10.1007/s40256-018-00321-5.
Mooradian AD. Evidence-Based Cardiovascular Risk Management in Diabetes. Am J Cardiovasc Drugs. 2019 Oct;19(5):439–448. https://doi.org/10.1007/s40256-019-00336-6.
Senatore F, Jagadeesh G, Rose M, Pillai VC, Hariharan S, Liu Q, McDowell TY, Sapru MK, Southworth MR, Stockbridge N. FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock. Am J Cardiovasc Drugs. 2019 Feb;19(1):11–20. https://doi.org/10.1007/s40256-018-0297-9.
Huet F, Akodad M, Kalmanovitch E, Adda J, Agullo A, Batistella P, Roubille C, Roubille F. Potential Uses of Sacubitril/Valsartan: Need for Data on Efficacy and Safety. Am J Cardiovasc Drugs. 2019 Feb;19(1):1–10. https://doi.org/10.1007/s40256-018-0306-z.
Social media sharing of information has become important and is another metric with which to measure the reach of articles. This year the following articles published in the American Journal of Cardiovascular Drugs scored highly on the Altmetric system:
Cao YX, Liu HH, Li S, Li JJ. A Meta-Analysis of the Effect of PCSK9-Monoclonal Antibodies on Circulating Lipoprotein (a) Levels. Am J Cardiovasc Drugs. 2019 Feb;19(1):87–97. https://doi.org/10.1007/s40256-018-0303-2.
Sheikh-Taha M. Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience. Am J Cardiovasc Drugs. 2019 Feb;19(1):59–64. https://doi.org/10.1007/s40256-018-0300-5.
Rago A, Papa AA, Cassese A, Arena G, Magliocca MCG, D’Onofrio A, Golino P, Nigro G, Russo V. Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study. Am J Cardiovasc Drugs. 2019 Aug;19(4):421–427. https://doi.org/10.1007/s40256-019-00341-9.
Deedwania P, Acharya T. Cardiovascular Protection with Anti-hyperglycemic Agents. Am J Cardiovasc Drugs. 2019 Jun;19(3):249–257. https://doi.org/10.1007/s40256-019-00325-9.
Goyal N, Skrdla P, Schroyer R, Kumar S, Fernando D, Oughton A, Norton N, Sprecher DL, Cheriyan J. Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects. Am J Cardiovasc Drugs. 2019 Jun;19(3):335–342. https://doi.org/10.1007/s40256-018-00320-6.
The quality of articles published in the journal is also reflected in its most recent impact factor of 2.578. The American Journal of Cardiovascular Drugs is now ranked 62/136 journals in the ‘Cardiac & Cardiovascular Systems’ category [Clarivate Analytics]. The Journal’s 2018 CiteScore is 2.12, with a ranking of 89/322 journals in the ‘Cardiology and Cardiovascular Medicine’ category [Scopus].
We thank the authors who have contributed articles to the American Journal of Cardiovascular Drugs over the course of 2019. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for the American Journal of Cardiovascular Drugs in the last 12 months:
Ran Abuhasira, Israel
Manyoo Agarwal, USA
Mehmet Agirbasli, Turkey
Satoshi Akagi, Japan
Aneta Aleksova, Italy
Marco Alings, The Netherlands
Turki A.I. Althunian, The Netherlands
Arturo Anadón, Spain
Dominick J. Angiolillo, USA
Jack E. Ansell, USA
Mohamed Ayan, USA
Philip Aylward, Australia
Ebru Aypar, Turkey
Upendra Baitha, India
Vinod K. Bansal, USA
Ayse Baysal, Turkey
Alessandro Belletti, Italy
Jerzy Beltowski, Poland
Manju B. Jayanna, USA
Giuseppe Biondi-Zoccai, Italy
Dirk J. Blom, South Africa
Sylvia Boesch, Austria
Kwadwo O. Bonsu, Malaysia
Giuseppe Boriani, Italy
Eliot A. Brinton, USA
Carlos Brotons, Spain
Liam R. Brunham, Canada
Levent Cerit, Cyprus
María Cespón Fernández, Spain
Oliver Chen, USA
Robert J. Chilton, USA
Ujjwal K. Chowdhury, India
Jennifer Clemente, USA
Ashish Correa, USA
Adam Cuker, USA
Fabrizio D’Ascenzo, Italy
Rita Del Pinto, Italy
Simon B. Dimmitt, Australia
Helena Domínguez, Denmark
Henning Drechsler, USA
Andre Rodrigues Duraes, Brazil
Jana B. Ernst, Germany
David Faraoni, Canada
Harrison W. Farber, USA
Anke C. Fender, Germany
Jonathan Fialkow, USA
Ashley N. Fox, USA
Hidekatsu Fukuta, Japan
Luis Furuya-Kanamori, Qatar
Mark M. Gallagher, UK
Sanjay Ganapathi, India
Carmine Gazzaruso, Italy
Eugenia Gkaliagkousi, Greece
Tyler Gluckman, USA
Isabelle Gouin-Thibault, France
Remco B. Grobben, The Netherlands
Garrie J. Haas, USA
Walter E. Haefeli, Germany
Benjamin Hibbert, Canada
Niels P.G. Hoedemaker, The Netherlands
Young Hoon Jeong, Republic of Korea
Wenjun Ju, USA
Chris J. Kapelios, Greece
Juan P. Kaski, UK
Michael S. Kelly, USA
Muhammad Shahzeb Khan, USA
Yaariv Khaykin, Canada
Moo Hyun Kim, Republic of Korea
Jonathan A. Kirk, USA
Robert Lasley, USA
Carl J. Lavie, USA
Astin Lee, Australia
David L. Jimenez, Spain
Danny Liew, Australia
Chulaporn Limwattananon, Thailand
Ping Ting Lin, Taiwan
Krister Lindmark, Sweden
Thomas F. Lindsay, Canada
Hua Ling, USA
Ran Liu, China
Peizhi Ma, China
Aaqib H. Malik, USA
Krzysztof Malinowski, Poland
Umit Yavuz Malkan, Turkey
Edoardo Mannucci, Italy
Antonis S. Manolis, Greece
Andrea Messori, Italy
Joan W. Miller, USA
Mark A. Munger, USA
Saul G. Myerson, UK
Tarek Nafee, USA
Toshiyuki Nagai, Japan
Nitish Naik, India
Kazuhiko Nakayama, Japan
Shane Nanayakkara, Australia
Marek Napierala, USA
Keumhan Noh, Canada
Kehinde O. Obamiro, Australia
Horst Olschewski, Austria
Vicki Osborne, UK
Roberto Padrini, Italy
Akhil Parashar, USA
Jesper Park-Hansen, Denmark
Sweta Patel, USA
Carlos Pérez-Sánchez, UK
Sylvie Perreault, Canada
Rebabonye B. Pharithi, Ireland
Pasquale Pignatelli, Italy
Marco Proietti, Italy
Alessandro Putzu, Switzerland
Sivasubramanian Ramakrishnan, India
Jamal S. Rana, USA
Bernhard Rauch, Germany
Stefan Reers, Germany
Zeljko Reiner, Croatia
Yousef Rezaei, Islamic Republic of Iran
Janine E. Roeters van Lennep, The Netherlands
Giuseppe M.C. Rosano, UK
Federica Saponaro, Italy
Chandler D. Schexnayder, USA
Stephan H. Schirmer, Germany
Sebastian Schneeweiss, USA
Gregory G. Schwartz, USA
Greg Scutt, UK
Jessica Shami, China
Jaekyu Shin, USA
Sara Själander, Sweden
Nika Skoro-Sajer, Austria
David M. Smadja, France
Mette Sogaard, Denmark
Rabie Soliman, Egypt
Erik S.G. Stroes, The Netherlands
Beth A. Taylor, USA
Paul D. Thompson, USA
Bruno Trimarco, Italy
Jean Triscott, Canada
Stella Trompet, The Netherlands
Sotirios Tsimikas, USA
Kengo Tsukahara, Japan
Konstantinos Tziomalos, Greece
Bharathi Upadhya, USA
Mate Vamos, Germany
Gurpreet S. Wander, India
Changqian Wang, China
Björn Wettermark, Sweden
Lingling Wu, USA
Xuanqian Xie, Canada
Ji Yin, China
Barak Zafrir, Israel
Michel Zeitouni, France
Henry Zhao, Australia
In addition, we would like to thank the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:
A. Michael Lincoff, Cleveland Clinic Foundation, Cleveland, OH, USA [Consulting Editor]
Balram Bhargava, All India Institute of Medical Sciences, New Delhi, India
Deepak L. Bhatt, Brigham and Women’s Hospital Heart & Vascular Center, Boston, MA, USA
Prakash C. Deedwania, University of California at San Francisco, Fresno, CA, USA
Naranjan S. Dhalla, Institute of Cardiovascular Sciences, Winnipeg, MB, Canada
Phillip A. Erwin, South Miami Heart Specialists, South Miami, FL, USA
Arthur M. Feldman, Temple University School of Medicine, Philadelphia, PA, USA
Valentin Fuster, Mount Sinai Medical Center, New York, NY, USA
Xavier Girerd, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Sidney Goldstein, Henry Ford Heart and Vascular Institute, Detroit, MI, USA
Joseph A. Hill, UT Southwestern Medical Center, Dallas, TX, USA
Gowraganahalli Jagadeesh, Silver Spring, MD, USA
Neal S. Kleiman, The Methodist DeBakey Heart Center, Houston, TX, USA
Antoine Lafont, Université Paris-Descartes, Paris, France
Thierry H. Le Jemtel, Tulane University Medical School, New Orleans, LA, USA
Mario Marzilli, University of Pisa, Pisa, Italy
Venu Menon, Cleveland Clinic, Cleveland, OH, USA
Gilles Montalescot, Pitié-Salpêtrière University Hospital, Paris, France
Doralisa Morrone, University of Pisa, Pisa, Italy
Stephen G. Nicholls, Monash University, Melbourne, Vic, Australia
Ali Oto, Hacettepe University School of Medicine, Ankara, Turkey
Bertram Pitt, University of Michigan Hospital, Ann Arbor, MI, USA
Silvia G. Priori, Fondazione Salvatore Maugeri, Pavia, Italy
C. Venkata S. Ram, Texas Blood Pressure Institute, Dallas, TX, USA
Gianpaolo Reboldi, University of Perugia, Perugia, Italy
Gaetano Santulli, Albert Einstein College of Medicine, New York, NY, USA
Johanne Silvain, Institut de Cardiologie, Paris, France
Kewal K. Talwar, Max Super Speciality Hospital, New Delhi, India
Michal Tendera, Medical University of Silesia, Katowice, Poland
Udho Thadani, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Alec Vahanian, Groupe Hospitalier Bichat-Claude Bernard, Paris, France
George W. Vetrovec, Virginia Commonwealth University, Richmond, VA, USA
Michael A. Weber, State University of New York, New York, NY, USA
William S. Weintraub, Christiana Care Health Services, Newark, DE, USA
Harvey D. White, Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
Nathen D. Wong, University of California at Irvine, Irvine, CA, USA
We do hope that you have found the articles published throughout the year in the American Journal of Cardiovascular Drugs to be interesting and informative. The editorial schedule for 2020 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.
With best wishes,
Amitabh Prakash
Rights and permissions
About this article
Cite this article
Acknowledgement to Referees. Am J Cardiovasc Drugs 19, 521–524 (2019). https://doi.org/10.1007/s40256-019-00385-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40256-019-00385-x